The US House of Representatives on Monday afternoon unanimously passed a wide-ranging bill via voice vote that will ...

Metsera, the well-funded obesity biotech from Population Health Partners and ARCH Venture Partners, has unveiled its first ...

Bluebird bio announced Tuesday morning that it is laying off 25% of its workforce and cutting expenses by 20%. The move comes ...

A UK-based synthetic biology startup has brought in $58 million from private investors to fund its work engineering cell ...

Biomedicines announced another pharma partnership Tuesday, agreeing to work on several protein therapies with the Swiss ...

A software startup has sued Epic on antitrust grounds, arguing that the electronic health records giant has orchestrated a ...

UCB’s Bimzelx scored three more FDA approvals on Monday, making it the first and only IL-17A and IL-17F inhibitor approved in ...

As the federal government is threatening Johnson & Johnson with fines related to its unilateral alterations to the 340B drug ...

A Johnson & Johnson subsidiary filed for bankruptcy in its third attempt to settle a vast majority of cases alleging its talc ...

Sanofi has stayed out of the obesity drug development bonanza, taking a wait-and-see approach while keeping an eye on ...

Black Diamond Therapeutics’ stock price $BDTX jumped more than 15% premarket Monday morning after the company reported its ...

For AI-focused startups seeking out pharma deals, they have to go through people like Greg Meyers, the chief digital and ...